This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Pediatrics, Other  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 2004;158:707.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 3 studies of bronchiolitis reported in the February issue of Archives of Pediatrics and Adolescent Medicine^1-3 demonstrate the disconnect between the evidence and the practice of pediatrics in America.

The study of Mull et al¹ comparing epinephrine and albuterol sulfate found no important difference in efficacy. They assert that both medications "work." The treatment groups were blinded. But since there was no placebo group, a placebo effect of medications (on the physicians) cannot be ruled out. The Respiratory Distress Assessment Instrument is the most subjective and showed the most medication effect. The respiratory rate is perhaps less subjective, and it did go down some. The mean room air oxygen saturation should be the least subjective assessment and that got worse with treatment according to Figure 4. However, they reported a "significant improvement" in this. Does that represent an error?

Mull et al state that taking chest radiographs and performing . . . [Full Text of this Article]

John DiTraglia, MD

Correspondence: Dr DiTraglia, Pediatrics, 717 Fifth St, Portsmouth, OH 45662 (jditrag@zoomnet.net).

RELATED ARTICLES

Bronchiolitis—Reply
Colette C. Mull and Richard J. Scarfone
Arch Pediatr Adolesc Med. 2004;158(7):707-708.
EXTRACT | FULL TEXT  

Bronchiolitis—Reply
Valerie J. King, W. Clayton Bordley, and Meera Viswanathan
Arch Pediatr Adolesc Med. 2004;158(7):708.
EXTRACT | FULL TEXT